Otevřený přístup k infrastruktuře VVC Brno

VUAB Pharma a.s. is the operator of the Research and Development Center for Cytostatic Medicines (VVC). In order to finance the project, grant funds from the OP PIK POTENTIAL support program were used in accordance with § 4 of Act No. 218/2000 Coll. on Budgetary Rules and Amendments to Certain Related Laws, and in accordance with the internal regulations of the Ministry of Industry and Trade (MPO) for project evaluation. Project registration number CZ.01.1.02/0.0/0.0/17_165/0015953, implementation site: Karásek 2262/1i, 621 00 Brno.

Under the conditions of the grant, the operator committed to providing open access to the technology, including the provision of expert and technical support. Open access means the possibility to conduct research, development, and innovation activities at the Research and Development Center, or the possibility to perform specific analyses for research and development under contractual conditions. Access is intended for individuals or organizations from the Czech Republic and abroad, subject to compliance with the operating rules and internal regulations of VUAB Pharma a.s. for entering the VVC premises. Applicants for open access should prepare an access request, which should be sent by email to mnovotna@vuab.cz. The applicant must submit the access request with sufficient advance notice (at least 2 months in advance), along with a specification of technical requirements for the measurements and a proposed date for implementation. When assigning the scope and duration of access, the applicant’s proposals will be taken into account, but the operator reserves the right to determine the scope and duration at its own discretion. Notification of granting or denying the request, including allocation of time and duration of access, will be provided within 1 month from the date of receipt of the complete request.

Upon request by the operator, the applicant must demonstrate why, how, and for what purpose they intend to use the technology, so that authorized personnel have the opportunity to verify whether the planned research, development, or innovation activities comply with the rules for providing open access. The applicant is obliged to demonstrate the professional competence of the employees who will participate in the measurements.

The price for providing open access is determined individually for each applicant based on the requirements for the individual instruments and the duration of their use. The price will be communicated to the applicant within 1 month from the submission of the request.

Technological equipment of the Research and Development Center for Cytostatic Medicines:

Gas chromatograph

TOC

Karl Fischer titrator

Equipment for the preparation, sterile filtration, and filling of cytostatic medicines

Moisture analyzer

Equipment for filling agar media, including sterilization

Automated staining system for microbiological tests

Equipment for depyrogenation of packaging material